AMN · Amn Healthcare Services Inc
Market Cap
$1.33B
Shares
38.73M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| Investor Event Transcript | 2026-06-08 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-05-04 | 2026-05-01 | |
| DEF 14A | 2026-03-18 | 2026-05-01 | |
| 10-K | 2026-02-20 | 2025-12-31 | |
| 8-K | 2026-02-19 | — | |
| 8-K | 2026-02-05 | 2026-01-30 | |
| 8-K | 2026-01-14 | — | |
| 8-K | 2025-12-11 | — | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-06 | — | |
| 8-K | 2025-09-22 | — | |
| 8-K | 2025-09-22 | — | |
| 10-Q | 2025-08-08 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-05-05 | 2025-05-02 | |
| DEF 14A | 2025-03-18 | 2025-05-02 | |
| 10-K | 2025-02-21 | 2024-12-31 | |
| 8-K | 2025-02-20 | — | |
| 8-K | 2025-02-07 | 2025-02-04 | |
| 8-K | 2024-11-12 | 2024-11-09 | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-11-07 | 2024-11-05 | |
| 8-K | 2024-10-03 | — | |
| 8-K | 2024-10-01 | — | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-09 | 2024-07-02 | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| 8-K | 2024-04-22 | 2024-04-19 | |
| DEF 14A | 2024-03-05 | 2024-04-19 | |
| 10-K | 2024-02-22 | 2023-12-31 | |
| 8-K | 2024-02-21 | 2024-02-17 | |
| 8-K | 2024-02-15 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-10-23 | — | |
| 10-Q | 2023-08-04 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-07-12 | 2023-07-06 | |
| 8-K | 2023-05-19 | 2023-05-17 | |
| 8-K | 2023-05-08 | — |
Showing 1–50 of 109 filings
Key facts
CIK
1142750
CUSIP
001744101
13F (30d)
235 filings
225 filers
Visit website
Investor relations